Riccardo Masson
Fondazione IRCCS Istituto Neurologico Carlo Besta(IT)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, RNA modifications and cancer, Muscle Physiology and Disorders, Congenital Anomalies and Fetal Surgery, RNA Research and Splicing
Most-Cited Works
- → Risdiplam in Type 1 Spinal Muscular Atrophy(2021)395 cited
- → Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls(2021)268 cited
- → Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial(2021)241 cited
- → Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2024)103 cited
- → Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial(2022)98 cited
- → Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment(2022)61 cited
- → Brain, cognition, and language development in spinal muscular atrophy type 1: a scoping review(2021)53 cited
- → Effect of Nusinersen on Respiratory Muscle Function in Different Subtypes of Type 1 Spinal Muscular Atrophy(2019)50 cited
- → Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients(2020)47 cited
- → Genetic modifiers of respiratory function in Duchenne muscular dystrophy(2020)44 cited